CASI Pharmaceuticals, Inc.
CASIF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962738
No open-market purchases or sales by CASI Pharmaceuticals, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $17 in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding CASI Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 1 | 21 | +20 |
| Shares | 100 | 929.8K | +929.7K (+929,695.0%) |
| Value | $179 | $2.15M | +$2.15M (+1,202,459.8%) |
New holders (20)
Institutions that held CASI Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 257,618 | $597.7K | 0.00% |
| Wellington Shields Capital Management, LLC | 180,143 | $417.9K | 0.05% |
| Wellington Shields & Co., LLC | 139,315 | $323.2K | 0.07% |
| Geode Capital Management, LLC | 98,133 | $225.7K | 0.00% |
| BlackRock Inc. | 91,715 | $212.8K | 0.00% |
| Susquehanna International Group, LLP | 38,326 | $88.2K | 0.00% |
| State Street Corp | 35,555 | $81.8K | 0.00% |
| Northern Trust Corp | 29,825 | $69.2K | 0.00% |
| Franklin Resources Inc | 24,923 | $57.3K | 0.00% |
| Renaissance Technologies LLC | 13,100 | $30.0K | 0.00% |
| Dimensional Fund Advisors LP | 11,508 | $26.5K | 0.00% |
| UBS Group AG | 6,175 | $14.3K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,674 | $4.00K | 0.00% |
| Morgan Stanley | 1,553 | $3.60K | 0.00% |
| Wells Fargo & Company | 62 | $144 | 0.00% |
| Northwestern Mutual Wealth Management Co | 13 | $30 | 0.00% |
| Colonial Trust Co | 11 | $26 | 0.00% |
| Bank of America Corp | 3 | $7 | 0.00% |
| JPMorgan Chase & Co | 25 | $0 | 0.00% |
| Royal Bank of Canada | 18 | $0 | 0.00% |
Sold out (0)
Institutions that held CASI Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
None.